Main Menu

Target Validation and DNA Damage Response Team

Professor Tutt’s team interests involve the discovery of novel therapies and biomarkers in BRCA1/BRCA2-associated cancers and ER/HER2-negative/basal-like breast cancers – including the identification of new drug targets and therapy combination strategies.

Team leader

Professor Andrew Tutt

Professor Andrew Tutt

Director, Breast Cancer Now Toby Robins Research Centre

Andrew Tutt is Head of the Division of Breast Cancer Research and Director of the Breast Cancer Now Toby Robins Research Centre at the ICR and Guy’s Hospital King’s College London. He is a Clinician Scientist with the Laboratory and Clinical Trials programme, and a Consultant Clinical Oncologist looking after women with breast cancer.

ORCID 0000-0001-8715-2901

Team members

Dr Nick Balan

Higher Scientific Officer

Dr Kathryn Davidson

Higher Scientific Officer

Dr Callum Walker

Postdoctoral Fellow

Dr Daniel Weekes

Senior Scientific Officer